Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "Press Release Alkem launches probiotic DSS , the original De Simone formulation, in India for gut health management".
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has launched DSS, a probiotic based on the original De Simone formulation, in the Indian market for gut health management. DSS is a well-known probiotic formulation developed by Professor Claudio De Simone, commonly used for digestive health. The company is introducing this product as part of its expansion in the gut health / probiotics segment in India. No financial figures, revenue projections, or order size details were disclosed in the filing.
This is a product launch in the growing gut health and probiotics category, which could support Alkem's consumer health and OTC portfolio. However, the announcement contains no material financial impact, so it is unlikely to move the stock significantly on its own.